Constraint Induced Movement Therapy (CIMT) for acquired brain injury: a clinical feasibility RCT.

Constraint Induced Movement Therapy (CIMT) for acquired brain injury: a clinical feasibility RCT investigating CIMT versus a Bobath based upper limb intervention.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN22105243

Enrollment

Registered

2015-02-02

Start date

2009-12-18

Completion date

Unknown

Last updated

2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired brain injury, specifically traumatic brain injury and stroke. Nervous System Diseases

Interventions

1. Constraint induced movement therapy for the upper limb (experimental) 2. Conventional interdisciplinary upper extremity programme (control)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Participants with upper limb treatment as a main therapy requirement 2. Male and female (aged = 18 years old) 3. Six months to five years post first episode of ABI (stroke or TBI) 4. Movement criteria: Have a minimum of the following criteria and be able to complete three times: 4.1. 100 wrist extension 4.2. 100 extension/abduction of the thumb 4.3. Extension of 2 fingers > 00 4.4 450 shoulder flexion and abduction 4.5. 200 elbow extension from 900 flexed position 5. Follow two part spoken or written commands 6. Perform their baseline level of mobility with the mitt on their less effected upper extremity including walking/transfer/wheelchair use (independently/with supervision/with assistance)

Exclusion criteria

Exclusion criteria: 1. Progressive neurological condition 2. Gross cognitive impairment or disorientation.

Design outcomes

Primary

Measure	Time frame
1. Motor activity log 2. Graded wolf motor function test The time points are baseline, immediately post intervention and three months post intervention completion	—

Secondary

Measure	Time frame
1. EuroQOL 2. Stroke self efficacy questionnaire 3. Hospital anxiety and depression scale The timepoints are baseline, immediately post intervention and three months post intervention completion	—

Countries

United Kingdom

Contacts

Public ContactKaty Pedlow

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026